本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Benitec Biopharma Limited

11.39
-0.6900-5.71%
成交量:16.90萬
成交額:193.08萬
市值:3.90億
市盈率:-12.20
高:12.12
開:12.11
低:11.08
收:12.08
52周最高:16.76
52周最低:9.85
股本:3,425.49萬
流通股本:1,792.50萬
量比:2.32
換手率:0.94%
股息:- -
股息率:- -
每股收益(TTM):-0.9338
每股收益(LYR):-1.0472
淨資產收益率:-29.58%
總資產收益率:-19.93%
市淨率:2.13
市盈率(LYR):-10.88

資料載入中...

2022/08/10

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2022/08/08

SEC問詢函

CORRESP [Cover] - Correspondence
2022/08/08

SEC問詢函

CORRESP [Cover] - Correspondence
2022/08/08

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2022/07/29

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2022/05/16

重要事件披露

8-K - Current report
2022/05/16

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/02/14

重要事件披露

8-K - Current report
2022/02/14

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/02/09

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/09

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/09

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/08

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/21

重要事件披露

8-K/A [Amend] - Current report
2022/01/13

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/12/23

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/12/21

重要事件披露

8-K - Current report
2021/12/13

重要事件披露

8-K - Current report
2021/05/12

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/07

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals